Vir Biotechnology (VIR) Gross Profit (2020 - 2026)
Vir Biotechnology (VIR) recorded Gross Profit of $238.95 million in Q2 2026, compared with $1.2 million a year earlier.
Powered by 
Analysis
Vir Biotechnology (VIR) Gross Profit (2020 - 2026) Analysis & Trends
On a TTM basis, Vir Biotechnology's Gross Profit came in at $254.87 million as of Jun 30, 2026; for FY2025, it came in at $68.53 million, down 6.6% from FY2024.
- Annual Gross Profit has declined for three straight years, with a five-year compound annual growth rate of -2.1% (FY2020 to FY2025).
- Across earlier years, Gross Profit came in at $73.36 million in FY2024 (-12.1%), $83.42 million in FY2023 (-94.3%), $1.47 billion in FY2022 (+42.7%) and $1.03 billion in FY2021.
- The Q2 2026 figure is the highest quarterly Gross Profit since Q3 2022.
- Peak year-over-year performance for Gross Profit in the last five years was growth of 267.8% in Q3 2022, against a decline of 99.3% in Q3 2023 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Vir Biotechnology | 1.89 Bn | 1.89 Bn | 238.95 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 238.95 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 3.03 Mn |
| Dec 31, 2024 | 11.69 Mn |
| Sep 30, 2024 | 2.33 Mn |
| Jun 30, 2024 | 3.02 Mn |
| Mar 31, 2024 | 56.32 Mn |
| Dec 31, 2023 | 15.99 Mn |
| Sep 30, 2023 | 2.60 Mn |
| Jun 30, 2023 | 3.78 Mn |
| Mar 31, 2023 | 61.05 Mn |
| Dec 31, 2022 | 43.41 Mn |
| Sep 30, 2022 | 352.30 Mn |
| Jun 30, 2022 | 12.71 Mn |
| Mar 31, 2022 | 1.14 Bn |
| Dec 31, 2021 | 755.87 Mn |
| Sep 30, 2021 | 95.78 Mn |
| Jun 30, 2021 | 175.92 Mn |
| Mar 31, 2021 | 1.98 Mn |
| Dec 31, 2020 | 1.73 Mn |
API Access
Vir Biotechnology Gross Profit API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-profit&ticker=VIR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-profit", "ticker": "VIR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gross-profit&ticker=VIR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();